PARIS (Bloomberg): Hydroxychloroquine, the 65-year-old malaria drug that US President Donald Trump has praised, appeared not to help patients get rid of the pathogen in a small study.
The pill did not help patients clear the virus better than standard care and was much more likely to cause side effects, according to a study of 150 hospitalised patients by doctors at 16 centres in China. The research, which has not been peer-reviewed, was released on Tuesday (April 14).
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
